UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000003770
Receipt number R000004565
Scientific Title A Phase II study of Pemetrexed plus Carboplatin Plus Bevacizumab followed by maintenance Pemetrexed Plus Bevacizumab in patients with previously untreated stage III/IV or post-operative recurrent non-squamous non-small-cell and lung cancer.
Date of disclosure of the study information 2010/06/21
Last modified on 2013/06/17 09:25:38

No. Disposal Last modified on Item of update
1 Insert 2010/06/17 11:14:00
2 Update 2011/12/20 09:56:19 Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2013/06/17 09:25:38 Recruitment status